找到约 59 条 “IOX4” 相关结果 （用时 0.11 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
M11006
|
IOX4 | IOX4 | HIF |
| IOX4 是一种选择性 PHD2 抑制剂，IC50 值为 1.6 nM，在细胞和野生型小鼠中诱导 HIFα 表达，可通透血脑屏障。IOX4 与 PHD2 活性位点的 2-氧代戊二酸 (2OG) 竞争并置换。 | |||
| M11621 | ChemBridge-5112759 | ChemBridge化合物-5112759 | Screening Compounds and Building Blocks |
| 1-(2-furylmethylene)-6-methyl-4-thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-one (5112759) | |||
| ChemBridge特有类药化合物/先导化合物-5112759，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11629 | ChemBridge-5114006 | ChemBridge化合物-5114006 | Screening Compounds and Building Blocks |
| ethyl 3-(benzylamino)-2-(3-chloro-1,4-dioxo-1,4-dihydro-2-naphthalenyl)-3-phenylacrylate (5114006) | |||
| ChemBridge特有类药化合物/先导化合物-5114006，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11635 | ChemBridge-5115807 | ChemBridge化合物-5115807 | Screening Compounds and Building Blocks |
| 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone (5115807) | |||
| ChemBridge特有类药化合物/先导化合物-5115807，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11641 | ChemBridge-5118173 | ChemBridge化合物-5118173 | Screening Compounds and Building Blocks |
| 3-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)-2-isopropyl-1,3-oxazolidine (5118173) | |||
| ChemBridge特有类药化合物/先导化合物-5118173，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11691 | ChemBridge-5140203 | ChemBridge化合物-5140203 | Screening Compounds and Building Blocks |
| 4-nitrophenyl (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetate (5140203) | |||
| ChemBridge特有类药化合物/先导化合物-5140203，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11692 | ChemBridge-5140317 | ChemBridge化合物-5140317 | Screening Compounds and Building Blocks |
| 2-(5-benzylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)-3-methylbutanoic acid (5140317) | |||
| ChemBridge特有类药化合物/先导化合物-5140317，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11693 | ChemBridge-5140589 | ChemBridge化合物-5140589 | Screening Compounds and Building Blocks |
| 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-oxo-4H-chromen-7-yl hexopyranoside (5140589) | |||
| ChemBridge特有类药化合物/先导化合物-5140589，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11697 | ChemBridge-5141565 | ChemBridge化合物-5141565 | Screening Compounds and Building Blocks |
| 4-amino-1-[6-(hydroxymethyl)-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxathiol-4-yl]-2(1H)-pyrimidinone hydrochloride (5141565) | |||
| ChemBridge特有类药化合物/先导化合物-5141565，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11710 | ChemBridge-5143717 | ChemBridge化合物-5143717 | Screening Compounds and Building Blocks |
| 5-{[5-(2,5-dichlorophenyl)-2-furyl]methylene}-3-methyl-2-thioxo-1,3-thiazolidin-4-one (5143717) | |||
| ChemBridge特有类药化合物/先导化合物-5143717，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11715 | ChemBridge-5146442 | ChemBridge化合物-5146442 | Screening Compounds and Building Blocks |
| 2,2'-{(4,4'-dioxo-2,2'-dithioxo-5,5'-bi-1,3-thiazolidine-3,3'-diyl)bis[(1-oxo-3,1-propanediyl)imino]}dibenzoic acid (5146442) | |||
| ChemBridge特有类药化合物/先导化合物-5146442，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11719 | ChemBridge-5148440 | ChemBridge化合物-5148440 | Screening Compounds and Building Blocks |
| 5-(4-chlorobenzylidene)-2-thioxo-1,3-thiazolidin-4-one (5148440) | |||
| ChemBridge特有类药化合物/先导化合物-5148440，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11720 | ChemBridge-5149378 | ChemBridge化合物-5149378 | Screening Compounds and Building Blocks |
| N-(5-chloro-2-pyridinyl)-6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinesulfonamide (5149378) | |||
| ChemBridge特有类药化合物/先导化合物-5149378，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11721 | ChemBridge-5149498 | ChemBridge化合物-5149498 | Screening Compounds and Building Blocks |
| 3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-(2-hydroxyphenyl)propanamide (5149498) | |||
| ChemBridge特有类药化合物/先导化合物-5149498，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11723 | ChemBridge-5149715 | ChemBridge化合物-5149715 | Screening Compounds and Building Blocks |
| 4-methyl-2-oxo-2H-chromen-7-yl {[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-4-oxo-4H-chromen-7-yl]oxy}acetate (5149715) | |||
| ChemBridge特有类药化合物/先导化合物-5149715，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11745 | ChemBridge-5158496 | ChemBridge化合物-5158496 | Screening Compounds and Building Blocks |
| sodium 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)butanoate (5158496) | |||
| ChemBridge特有类药化合物/先导化合物-5158496，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11746 | ChemBridge-5158497 | ChemBridge化合物-5158497 | Screening Compounds and Building Blocks |
| 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-hydroxybutanamide (5158497) | |||
| ChemBridge特有类药化合物/先导化合物-5158497，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11748 | ChemBridge-5158906 | ChemBridge化合物-5158906 | Screening Compounds and Building Blocks |
| 3-allyl-5-(2-furylmethylene)-2-thioxo-1,3-thiazolidin-4-one (5158906) | |||
| ChemBridge特有类药化合物/先导化合物-5158906，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11751 | ChemBridge-5161874 | ChemBridge化合物-5161874 | Screening Compounds and Building Blocks |
| 3-ethyl-5-(1-methyl-2(1H)-pyridinylidene)-2-thioxo-1,3-thiazolidin-4-one (5161874) | |||
| ChemBridge特有类药化合物/先导化合物-5161874，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11752 | ChemBridge-5162044 | ChemBridge化合物-5162044 | Screening Compounds and Building Blocks |
| 5-(2-nitrobenzylidene)-2-thioxo-1,3-thiazolidin-4-one (5162044) | |||
| ChemBridge特有类药化合物/先导化合物-5162044，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11757 | ChemBridge-5170837 | ChemBridge化合物-5170837 | Screening Compounds and Building Blocks |
| 5-(3,4-dihydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one (5170837) | |||
| ChemBridge特有类药化合物/先导化合物-5170837，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11758 | ChemBridge-5171838 | ChemBridge化合物-5171838 | Screening Compounds and Building Blocks |
| 2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid -2-ethyl-3,9-dimethyl-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]azepin-4-amine (1:1) (5171838) | |||
| ChemBridge特有类药化合物/先导化合物-5171838，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11789 | ChemBridge-5186324 | ChemBridge化合物-5186324 | Screening Compounds and Building Blocks |
| N-(4-bromophenyl)-2-(4-{[(4-bromophenyl)amino]carbonyl}phenyl)-1,3-dioxo-5-isoindolinecarboxamide (5186324) | |||
| ChemBridge特有类药化合物/先导化合物-5186324，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11796 | ChemBridge-5190839 | ChemBridge化合物-5190839 | Screening Compounds and Building Blocks |
| 1-({2-[2-(4-tert-butylphenyl)ethyl]-1,3-dioxolan-4-yl}methyl)piperidine (5190839) | |||
| ChemBridge特有类药化合物/先导化合物-5190839，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11802 | ChemBridge-5200824 | ChemBridge化合物-5200824 | Screening Compounds and Building Blocks |
| 5-(4-isopropylbenzylidene)-2-thioxo-1,3-thiazolidin-4-one (5200824) | |||
| ChemBridge特有类药化合物/先导化合物-5200824，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11809 | ChemBridge-5210574 | ChemBridge化合物-5210574 | Screening Compounds and Building Blocks |
| 4-(4-{[2-(1-naphthyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl]carbonyl}phenoxy)benzoic acid (5210574) | |||
| ChemBridge特有类药化合物/先导化合物-5210574，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11822 | ChemBridge-5212809 | ChemBridge化合物-5212809 | Screening Compounds and Building Blocks |
| N-[3-(dimethylamino)-1,4-dioxo-1,4-dihydro-2-naphthalenyl]acetamide (5212809) | |||
| ChemBridge特有类药化合物/先导化合物-5212809，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11840 | ChemBridge-5217444 | ChemBridge化合物-5217444 | Screening Compounds and Building Blocks |
| 6-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-hydroxyhexanamide (5217444) | |||
| ChemBridge特有类药化合物/先导化合物-5217444，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11855 | ChemBridge-5225515 | ChemBridge化合物-5225515 | Screening Compounds and Building Blocks |
| 5-{[5-(4-bromophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one (5225515) | |||
| ChemBridge特有类药化合物/先导化合物-5225515，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11863 | ChemBridge-5228930 | ChemBridge化合物-5228930 | Screening Compounds and Building Blocks |
| 5-(2,3-dihydro-1,4-benzodioxin-2-yl)-4H-1,2,4-triazole-3-thiol (5228930) | |||
| ChemBridge特有类药化合物/先导化合物-5228930，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M2134
|
Vortioxetine hydrobromide | 沃替西汀氢溴酸 | 5-HT Receptor |
| Lu AA21004 | |||
| Vortioxetine (Lu AA21004) HBr是一种5-羟色胺抑制剂，抑制5-HT1A， 5-HT1B， 5-HT3A， 5-HT7受体和SERT，IC50分别为15 nM， 33 nM， 3.7 nM， 19 nM和1.6 nM。 | |||
| M4943
|
3,4,5-Trimethoxyphenylacetic acid | 3,4,5-Trimethoxyphenylacetic acid | Metabolite/Endogenous Metabolite |
| Cell suspensions did not release carbon dioxide from 3,4-[methoxyl-14C]dihydroxy-5-methoxyphenylacetate but accumulated 1 mol of methanol per mol of 3,4,5-trimethoxyphenylacetate oxidized. | |||
| M6831
|
IOX1 | IOX1 | Histone demethylase |
| IOX-1 | |||
| IOX1是一个2OG oxygenases强效的广谱抑制剂，对KDM4A和KDM3A的IC50值分别为0.6 uM和0.1 uM。IOX1也抑制ALKBH5。 | |||
| M43847 | 1-(4-(2,6-dioxopiperidin-3-yl)phenyl)piperidine-4-carbaldehyde | 1-[4-(2,6-二氧代-3-哌啶基)苯基]哌啶-4-甲醛 | Ligand for E3 Ligase |
| 4-Piperidinecarboxaldehyde, 1-[4-(2,6-dioxo-3-piperidinyl)phenyl]- | |||
| 1-(4-(2,6-dioxopiperidin-3-yl)phenyl)piperidine-4-carbaldehyde | |||
| M10799 | BMS-986242 | BMS-986242 | IDO |
| BMS-986242 是一种具有口服活性、强效和选择性的 indoleamine-2,3-dioxygenase 1 (IDO1) 抑制剂。BMS-986242 可用于癌症研究。 | |||
| M16349 | 9β,13β-Epidioxyabiet-8(14)-en-18-oic acid | 9β,13β-Epidioxyabiet-8(14)-en-18-oic acid | Diterpenoids |
| 9β,13β-Epidioxyabiet-8(14)-en-18-oic acid | |||
| M16895 | 2,3-Di(3',4'-methylenedioxybenzyl) -2-buten-4-olide | 2,3-Di(3',4'-methylenedioxybenzyl) -2-buten-4-olide | Lignans |
| 2,3-Di(3',4'-methylenedioxybenzyl) -2-buten-4-olide | |||
| M16993 | 2-(2,2-Dimethyl-1,3-dioxolan -4-yl)propane-1,2-diol | 2-(2,2-Dimethyl-1,3-dioxolan -4-yl)propane-1,2-diol | Others |
| 2-(2,2-Dimethyl-1,3-dioxolan -4-yl)propane-1,2-diol | |||
| M16994 | 1,6-Dioxaspiro[4.5]decan-2-methanol | 1,6-Dioxaspiro[4.5]decan-2-methanol | Others |
| 1,6-Dioxaspiro[4.5]decan-2-methanol | |||
| M17947 | Chol-8-en-24-oic acid, 7,15-dihydroxy-4,4,14-trimethyl-3,11-dioxo-, (5α)- | Chol-8-en-24-oic acid, 7,15-dihydroxy-4,4,14-trimethyl-3,11-dioxo-, (5α)- | Others |
| 7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid 是一种灵芝三萜类化合物（灵芝中重要的生物活性成分，可用于研究慢性肝病）。 | |||
| M29484 | IDO-IN-13 | IDO-IN-13 | IDO |
| IDO-IN-13 是一种有效的 indoleamine 2,3-dioxygenase 1 (IDO1) 抑制剂，EC50 值为 17 nM，详细信息请参考 WO2019040102A1，example 43。 | |||
| M43876 | 1,1-Dimethylethyl 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate | 1,1-Dimethylethyl 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate | Ligand for E3 Ligase |
| 1,1-Dimethylethyl 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate | |||
| M29809 | NU223612 | NU223612 | PROTAC |
| NU223612 是一种有效的 PROTAC (PROTACs)，可降解吲哚胺 2,3-双加氧酶 1 (IDO1) (Indoleamine 2,3-Dioxygenase (IDO))，Kd 为 640 nM。NU223612 通过 CRBN 介导的蛋白酶体降解有效降解 IDO1 蛋白。NU223612 以 290 nM 的亲和力与 CRBN 结合。NU223612 可以穿过血脑屏障 (BBB)。 | |||
| M31050 | Rivanicline hemioxalate | Rivanicline hemioxalate | AChR/AChE |
| RJR-2403 hemioxalate; (E)-Metanicotine hemioxalate | |||
| Rivanicline hemioxalate (RJR-2403 hemioxalate; (E)-Metanicotine hemioxalate) 是神经元烟碱受体 (neuronal nicotinic receptor) 激动剂，对 α4β2 亚型有高度选择性，Ki 为 26 nM，而对 α7 受体的 Ki 则为3.6 μM。 | |||
| M38771 | 1,4-Epidioxybisabola-2,10-dien-9-one | 1,4-Epidioxybisabola-2,10-dien-9-one | Anti-infection |
| 1,4-Epidioxybisabola-2,10-dien-9-one 是 1,4-epidioxy-bisabola-2,12-diene 的衍生物，可从 Curcuma longa L. 中分离出来。1,4-Epidioxybisabola-2,10-dien-9-one 在 MDCK 细胞系中表现出抗流感病毒 A/PR/8/34 (H1N1) 的抗病毒活性，IC50 为 16.79 ± 4.03 μg/mL。 | |||
| M40195 | 3,4-Methylenedioxycinnamic acid | 3,4-Methylenedioxycinnamic acid | Others |
| 3,4-Methylenedioxycinnamic acid 是 phenylpropanoid enzyme 4-hydroxycinnamoyl-CoA 连接酶 的抑制剂。3,4-Methylenedioxycinnamic acid 会促进可溶性酚，尤其是香草酸的形成。 | |||
| M41161 | Helioxanthin | Helioxanthin | Anti-infection |
| Helioxanthin (ACH126447) 具有体外抗病毒活性，对HBV的EC50为1 μM，还可抗黄病毒。 | |||
| M41897 | RTIOXA-43 | RTIOXA-43 | OX Receptor |
| RTIOXA-43 是一种食欲素受体 (orexin receptor) 激动剂，对于 OX2 和 OX1 受体的 EC50 值均为 24 nM。 | |||
| M43851 | 1-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-4-piperidineacetic acid | 1-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-4-piperidineacetic acid | Ligand for E3 Ligase |
| 1-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-4-piperidineacetic acid | |||
| M43860 | 1-[5-(2,6-Dioxo-3-piperidinyl)-3-fluoro-2-pyridinyl]-4-piperidineacetic acid | 1-[5-(2,6-Dioxo-3-piperidinyl)-3-fluoro-2-pyridinyl]-4-piperidineacetic acid | Ligand for E3 Ligase |
| 1-[5-(2,6-Dioxo-3-piperidinyl)-3-fluoro-2-pyridinyl]-4-piperidineacetic acid | |||
| M43875 | 2(1H)-Isoquinolineacetic acid, 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro- | 2(1H)-Isoquinolineacetic acid, 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro- | Ligand for E3 Ligase |
| 2(1H)-Isoquinolineacetic acid, 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro- | |||
| M43882 | 1-(4-(2,4-Dioxotetrahydropyrimidin-1(2H)-yl)phenyl)piperidine-4-carbaldehyde | 1-(4-(2,4-二氧代四氢嘧啶-1(2H)-基)苯基)哌啶-4-甲醛 | Ligand for E3 Ligase |
| 4-Piperidinecarboxaldehyde, 1-[4-(tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)phenyl]- | |||
| 1-(4-(2,4-Dioxotetrahydropyrimidin-1(2H)-yl)phenyl)piperidine-4-carbaldehyde | |||
| M43884 | 1-[4-(Tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)phenyl]-4-piperidinecarboxylic acid | 1-[4-(Tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)phenyl]-4-piperidinecarboxylic acid | Ligand for E3 Ligase |
| 1-[4-(Tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)phenyl]-4-piperidinecarboxylic acid | |||
| M43887 | 1-(5-(2,4-Dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)piperidine-4-carbaldehyde | 1-(5-(2,4-二氧代四氢嘧啶-1(2H)-基)吡啶-2-基)哌啶-4-甲醛 | Ligand for E3 Ligase |
| 4-Piperidinecarboxaldehyde, 1-[5-(tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-pyridinyl]- | |||
| 1-(5-(2,4-Dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)piperidine-4-carbaldehyde | |||
| M43892 | 3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-4-fluorobenzoic acid | 3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-4-fluorobenzoic acid | Ligand for E3 Ligase |
| Benzoic acid, 4-fluoro-3-(tetrahydro-2,4-dioxo-1(2H)-pyrimidinyl)- | |||
| 3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-4-fluorobenzoic acid | |||
| M44119 | Isonemerosin | (E)-alpha-(3,4-Methylenedioxybenzylidene)-beta-(3,4,5-trimethoxybenzyl)-gamma-butyrolactone | Others |
| (E)-alpha-(3,4-Methylenedioxybenzylidene)-beta-(3,4,5-trimethoxybenzyl)-gamma-butyrolactone | |||
| M44596 | 11alpha-hydroxy-3,7-dioxo-5alpha-lanosta-8,24(E)-dien-26-oic acid | 11alpha-hydroxy-3,7-dioxo-5alpha-lanosta-8,24(E)-dien-26-oic acid | Others |
| 11alpha-hydroxy-3,7-dioxo-5alpha-lanosta-8,24(E)-dien-26-oic acid | |||
| M56076 | Tedatioxetine hydrobromide | Tedatioxetine hydrobromide | 5-HT Receptor |
| Tedatioxetine (Lu AA24530) hydrobromide 是一种倾向于 5-羟色胺、去甲肾上腺素的三重再摄取抑制剂，且是 5-HT2A，5-HT2C，5-HT3 和 α1A 肾上腺素能受体拮抗剂。 | |||
| M56091 | Tedatioxetine | Tedatioxetine | 5-HT Receptor |
| Tedatioxetine (Lu AA24530) 是一种倾向于 5-羟色胺、去甲肾上腺素的三重再摄取抑制剂，且是 5-HT2A，5-HT2C，5-HT3 和 α1A 肾上腺素能受体拮抗剂。 | |||
